MAPT and Alzheimer disease: To date, the removal of abnormal pathogenic proteins (Aβ deposition and phosphorylated Tau protein accumulation) in the brain is still the first option for AD treatment (Blennow, Hampel, & Zetterberg, 2014; Yuan, Yidan, Jian, Xiangjian, & Guofeng, 2020).